Literature DB >> 23497417

Anti-oxidative trypanocidal drugs, myth or reality.

Soodabeh Saeidnia1.   

Abstract

Entities:  

Year:  2013        PMID: 23497417      PMCID: PMC3599955          DOI: 10.1186/2008-2231-21-21

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


× No keyword cloud information.

Sir, “Blueberries best be eaten because they taste good, not because their consumption will lead to less cancer.” Prof. Jim Watson [1]. Recently, Professor Jim Watson, father of DNA double-helix, has described in his paper that antioxidant supplements may have caused more cancers than they have prevented. Alongside this controversial, several papers give rise on looking for anti-cancers among antioxidants [2-4]. In reality, mechanism of anti-cancer action is very important, where induction of free radicals and augmentation of Reactive Oxygen Species (ROS) are the main pharmacological modes of anti-neoplastic activity [5]. In spite of the fact that beneficial role of antioxidants in chemoprevention of cancer has been well-known, effectiveness of them in treatment of cancer is still in challenge. Interestingly, there is a similar situation for another important disease, Chagas (American trypanosomiasis), a tropical parasitic illness caused by the flagellate protozoan Trypanosoma cruzi and affects eight to 10 million people residing in Latin American countries [6,7]. Nowadays natural compounds have been evaluated for discovery of new chemotherapeutics in treatment of Chagas disease. But, literature revealed that most of the researchers select the compounds without attention to their probable antioxidant activity, while therapeutic action of the remarkable trypanocidal compounds like elatol involves mitochondria as the primary target leading to increase of ROS generation through the electron transport chain, which consequently affects cell membrane and DNA integrity and finally death of parasite [8]. Although this is not the only mechanism of action for trypanocidal drugs, well-known natural phenolics such as gallic acid can act via pro-oxidant activity as well as enhancing DNA single-strand breaks to kill Trypanosoma[9]. Furthermore, anti-trypanosoma activity of komaroviquinone (a diterpenoid) was found to be attributed by generation of ROS catalyzed by T. cruzi old yellow enzyme [10]. It seems that potent natural antioxidants like hydroxycoumarins derivatives or flavonoids are not potentially strong trypanocidal agents [11]. The question arise from this concept is “why does a physician recommend consumption of antioxidant in treatment of trypanosomiasis?” The answer to this question may be hidden behind the differences in mechanism of actions for trypanocidal drugs and also the role of antioxidants in prevention of inflammation in this illness. To the best of our knowledge, consumption of antioxidant supplements is new perspective in therapy of Chagas disease because of the attenuation of oxidative stress associated to this disease [12]. Additionally, it has been reported that Trypanosoma infection decreases the levels of reduced glutathione (GSH) in the blood, liver, kidney, and also the plasma levels of vitamin C [13]. For this reason, they believe that supplementation of infected patient with vitamin C could prevent the depletion of endogenous antioxidants. Actually, another probable reason for this entrenched attitude is the ubiquitous application of antioxidant supplements. Therefore, we recommend the researchers to focus on possible mode of actions for trypanocidal candidates, especially when the nominated compounds are proved to possess antioxidant ability.

Competing interest

The author declared that there is no competing interest.
  9 in total

1.  Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme.

Authors:  Nahoko Uchiyama; Zakayi Kabututu; Bruno K Kubata; Fumiyuki Kiuchi; Michiho Ito; Junko Nakajima-Shimada; Takashi Aoki; Kei Ohkubo; Shunichi Fukuzumi; Samuel K Martin; Gisho Honda; Yoshihiro Urade
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.

Authors:  Fernanda Pérez-Cruz; Silvia Serra; Giovanna Delogu; Michel Lapier; Juan Diego Maya; Claudio Olea-Azar; Lourdes Santana; Eugenio Uriarte
Journal:  Bioorg Med Chem Lett       Date:  2012-07-13       Impact factor: 2.823

3.  Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.

Authors:  Leonilda Banki Maçao; Danilo Wilhelm Filho; Roberto Coury Pedrosa; Aline Pereira; Patrícia Backes; Moacir Aloisio Torres; Tânia Silva Fröde
Journal:  Int J Cardiol       Date:  2007-02-27       Impact factor: 4.164

4.  Two new monoterpene glycosides and trypanocidal terpenoids from Dracocephalum kotschyi.

Authors:  Soodabeh Saeidnia; Ahmad Reza Gohari; Nahoko Uchiyama; Michiho Ito; Gisho Honda; Fumiyuki Kiuchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-10       Impact factor: 1.645

5.  Formation of reactive oxygen intermediates might be involved in the trypanocidal activity of gallic acid.

Authors:  M Nose; T Koide; K Morikawa; M Inoue; Y Ogihara; Y Yabu; N Ohta
Journal:  Biol Pharm Bull       Date:  1998-06       Impact factor: 2.233

6.  Trypanocidal action of (-)-elatol involves an oxidative stress triggered by mitochondria dysfunction.

Authors:  Vânia Cristina Desoti; Danielle Lazarin-Bidóia; Daniela Bueno Sudatti; Renato Crespo Pereira; Antonio Alonso; Tania Ueda-Nakamura; Benedito Prado Dias Filho; Celso Vataru Nakamura; Sueli De Oliveira Silva
Journal:  Mar Drugs       Date:  2012-08-03       Impact factor: 6.085

7.  Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?

Authors:  Mohammad Abdollahi; Seyed Vahid Shetab-Boushehri
Journal:  Daru       Date:  2012-10-20       Impact factor: 3.117

8.  Antioxidant as an anticancer: consideration.

Authors:  Viroj Wiwanitkit; Kamon Chaiyasit
Journal:  Daru       Date:  2012-12-19       Impact factor: 3.117

9.  Oxidants, antioxidants and the current incurability of metastatic cancers.

Authors:  Jim Watson
Journal:  Open Biol       Date:  2013-01-08       Impact factor: 6.411

  9 in total
  1 in total

1.  Biogenic trypanocidal sesquiterpenes: lead compounds to design future trypanocidal drugs - a mini review.

Authors:  Soodabeh Saeidnia; Ahmad Reza Gohari; Azita Haddadi
Journal:  Daru       Date:  2013-05-15       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.